Tirzepatide vs 5-Amino-1MQ

Tirzepatide wins for raw weight-loss potency, appetite suppression, and clinically verified fat-loss (~15–21% total bodyweight drop at higher doses). Best-in-class for rapid reduction phases and users needing serious appetite governance. Protocols are more established, but tolerability (GI effects) and muscle retention require active management.

5-Amino-1MQ wins for body-recomposition without muscle loss, side-effect profile (no nausea or stim crash), convenience (oral dosing), and compatibility with GLP-1s or longevity stacks. The effect size on the scale is modest—but it uniquely shifts calorie partitioning in a muscle-sparing direction, and the safety/tolerability lets you stay on it long term.

Pick Tirzepatide if:

• You want aggressive, clinically validated fat loss in the shortest time frame
• Appetite control is the main barrier to your cut or contest prep
• You're stacking with test/protein/creatine and can actively defend lean mass
• Microdose protocols for a "lean bulk" or sustained calorie drift sound appealing
• You don't mind a weekly subQ injection and can manage transient GI sides

Pick 5-Amino-1MQ if:

• You're after body recomposition: lose fat, preserve (or improve) muscle
• Want a non-stimulant, non-suppressive oral fat loss tool for daily use
• Planning to stack with GLP-1s for muscle preservation during aggressive cuts
• Running longevity or NAD+ optimization protocols
• Need to avoid appetite suppression, GI sides, or want minimal side effects